Retrieve available abstracts of 13 articles: HTML format
Single Articles
May 2025
LI X, Cai Y, Yang J, Huang C, et al Parous female donor is not inferior to the young male donor under the low-dose
ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical
peripheral blood stem cell transplantation.
Leuk Res. 2025;154:107721. PubMedAbstract available
April 2025
AUBREY BJ, Blonquist T, McMasters M, Hobbs G, et al A phase I clinical trial of lenalidomide combined with bortezomib for acute
myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell
transplantation.
Leuk Res. 2025;153:107693. PubMedAbstract available
January 2025
CHO H, Kim J, Park Y, Lee BH, et al The presence of clonal isotype switch after autologous stem cell transplantation
as a prognostic biomarker for long-term survival in patients with multiple
myeloma.
Leuk Res. 2025;149:107641. PubMedAbstract available
December 2024
SHAHZAD M, Iqbal Q, Amin MK, Irfan S, et al Outcomes of hematopoietic stem cell transplantation in primary plasma cell
leukemia: A systematic review and meta-analysis.
Leuk Res. 2024;148:107640. PubMedAbstract available
November 2024
ROUZBAHANI M, Mousavi SA, Hajianfar G, Ghanaati A, et al Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic
hematopoietic stem cell transplantation using machine learning techniques.
Leuk Res. 2024;148:107619. PubMedAbstract available
LUCCHINI G, Cozma E, Jackson A, Gilmour K, et al COVID-19 infection in adult and paediatric recipients of allogeneic stem cell
transplantation: The UK experience.
Leuk Res. 2024;147:107618. PubMed
HUANG X, Wu X, Wang S, Ren Y, et al Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to
haploidentical allogeneic hematopoietic stem cell transplantation in
hematological malignancies with extramedullary involvement: Insights from a
single center.
Leuk Res. 2024;147:107617. PubMed
October 2024
WAIS V, Gantner A, Strauss K, Neagoie A, et al Treatment of steroid-refractory acute/chronic graft versus host disease: A
single-center real-world experience of ruxolitinib in combination with
extracorporeal photopheresis in a high-risk population.
Leuk Res. 2024;147:107611. PubMedAbstract available
August 2024
SHIMIZU H, Kato J, Tanoue S, Kimura SI, et al Allogeneic stem cell transplant with TBI-based myeloablative conditioning in
adolescents and young adults with Philadelphia chromosome-negative ALL treated
with pediatric protocols.
Leuk Res. 2024;144:107562. PubMedAbstract available
April 2024
INDRAN T, Das T, Muirhead J, O'Brien M, et al Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT)
in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A
longitudinal retrospective study using peripheral blood (PB) CD34(+) and CD3(+)
donor chim
Leuk Res. 2024;142:107504. PubMedAbstract available
ASHOURI K, Ginosyan AA, Chu M, Hom B, et al Donor matters: Donor selection impact on hematopoietic stem cell transplantation
outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights
from a myeloablative HSCT study.
Leuk Res. 2024;141:107501. PubMedAbstract available
March 2024
BRUNETTI M, Iasenza IA, Jenner AL, Raynal NJ, et al Mathematical modelling of clonal reduction therapeutic strategies in acute
myeloid leukemia.
Leuk Res. 2024;140:107485. PubMedAbstract available
KILIC GUNES E, Yigit Kaya S, Yaman F, Yeniay MK, et al Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell
transplantation: A multicenter real-world experience.
Leuk Res. 2024;140:107484. PubMedAbstract available